Literature DB >> 32113113

Course and prognosis of adult-onset epilepsy in Brazil: A cohort study.

Ana Letícia F Caprara1, Jamir P Rissardo2, Martim T B Leite2, Juliana O F Silveira2, Paulo G M Jauris2, Josi Arend3, Aline Kegler4, Luiz Fernando Freire Royes5, Michele Rechia Fighera2.   

Abstract

BACKGROUND: Most of the epilepsy longitudinal studies have analyzed children. However, in endemic regions, such as Brazil, neurocysticercosis accounts for many adult-onset epilepsy cases. So, the main objective of this study was to identify the clinical predictors associated with drug-resistant adult-onset epilepsy in Brazil during a long-term follow-up.
METHODS: We followed 302 individuals with adult-onset epilepsy for 9.8 years in our University Hospital. Structured questionnaires about drug-resistant epilepsy were applied. The presence of drug-resistant epilepsy was the primary outcome. We used multilevel linear modeling in our data analysis.
RESULTS: Overall 47 (15.6%) individuals presented drug-resistant epilepsy and the etiology was structural in 70.2% of them, while infectious etiology was present in 8.5% of this group. Infectious etiology occurred in 25.9% (n = 66) of the patients from the nondrug-resistant group. Those with developmental delay were two times more likely to present seizures. Structural epilepsy etiology was associated with an increased chance of relapsing. Poor school performance and abnormal electroencephalogram were also associated with an increased chance of seizures.
CONCLUSION: The course of epilepsy was favorable in the majority of our patients, and drug-resistant epilepsy rates were similar to those found in other studies, although we evaluated older individuals with higher levels of infectious etiology. Also, we found that neurocysticercosis was associated with well-controlled epilepsy, while structural epilepsy was directly related to the occurrence of seizures. We also hypothesized that the smaller size of lesions found in neurocysticercosis could contribute to better treatment response.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult; Cohort; Course; Drug-resistant; Epilepsy; Prognosis

Mesh:

Substances:

Year:  2020        PMID: 32113113     DOI: 10.1016/j.yebeh.2020.106969

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Screening of Risk Factors for Poor Prognosis in Patients with Refractory Epilepsy Secondary to Encephalomalacia.

Authors:  Yinjun Zhong
Journal:  Comput Math Methods Med       Date:  2022-07-04       Impact factor: 2.809

2.  Epidemiologic Profile of Patients With Epilepsy in a Region of Southeast Brazil: Data From a Referral Center.

Authors:  Renata Parissi Buainain; Carlos Tadeu Parisi Oliveira; Fernando Augusto Lima Marson; Manoela Marques Ortega
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

3.  Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador.

Authors:  Oscar H Del Brutto; Bettsy Y Recalde; Robertino M Mera
Journal:  Am J Trop Med Hyg       Date:  2021-10-11       Impact factor: 3.707

Review 4.  Neurocysticercosis and movement disorders: A literature review.

Authors:  Jamir Pitton Rissardo; Ana Letícia Fornari Caprara; Ícaro Durante
Journal:  Brain Circ       Date:  2020-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.